Topic: HIV

Merck

31. Pifeltro

Merck won a late-summer approval for new drugs Pifeltro and Delstrigo for adult patients with HIV-1 who haven’t had prior antiretroviral treatments.
Electromicrograph showing an HIV-infected T cell in blue and yellow

5. Trogarzo

Trogarzo represents the first HIV therapy with a new mechanism of action approved in more than a decade.
biktarvy

2. Biktarvy

Biktarvy combines the novel integrase inhibitor bictegravir with Gilead's own Descovy, a combo of emtricitabine and tenofovir alafenamide.